html5-img
1 / 11

Aarkstore - Hyperlipidemia - Pipeline Review, H2 2014

‘Hyperlipidemia - Pipeline Review, H2 2014’, provides an overview of the Hyperlipidemia’s therapeutic pipeline. For more details : http://goo.gl/UPSI67

Shubhangi
Download Presentation

Aarkstore - Hyperlipidemia - Pipeline Review, H2 2014

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Aarkstore - Hyperlipidemia - Pipeline Review, H2 2014 www.aarkstore.com

  2. Summary ‘Hyperlipidemia - Pipeline Review, H2 2014’, provides an overview of the Hyperlipidemia’s therapeutic pipeline. This Market Research Report provides comprehensive information on the therapeutic development for Hyperlipidemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hyperlipidemia and special features on late-stage and discontinued projects. www.aarkstore.com www.aarkstore.com

  3. Scope - The report provides a snapshot of the global therapeutic landscape of Hyperlipidemia- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Hyperlipidemia and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Hyperlipidemia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages- A detailed assessment of monotherapy and combination therapy pipeline projects- Coverage of the Hyperlipidemia pipeline on the basis of target, MoA, route of administration and molecule type- Latest news and deals relating related to pipeline products www.aarkstore.com

  4. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Hyperlipidemia- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Hyperlipidemia pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline www.aarkstore.com

  5. Table of Contents Introduction Global Markets Direct Report Coverage Hyperlipidemia Overview Therapeutics Development Pipeline Products for Hyperlipidemia - Overview Pipeline Products for Hyperlipidemia - Comparative Analysis Hyperlipidemia - Therapeutics under Development by Companies Hyperlipidemia - Therapeutics under Investigation by Universities/Institutes Hyperlipidemia - Pipeline Products Glance Clinical Stage Products Early Stage Products www.aarkstore.com

  6. List Of Tables Number of Products under Development for Hyperlipidemia, H2 2014 Number of Products under Development for Hyperlipidemia - Comparative Analysis, H2 2014 Number of Products under Development by Companies, H2 2014 Number of Products under Development by Companies, H2 2014 (Contd..1) Number of Products under Investigation by Universities/Institutes, H2 2014 Comparative Analysis by Clinical Stage Development, H2 2014 Comparative Analysis by Early Stage Development, H2 2014 Products under Development by Companies, H2 2014Products under Development by Companies, H2 2014 (Contd..1) Products under Development by Companies, H2 2014 (Contd..2) www.aarkstore.com

  7. List Of Figures Number of Products under Development for Hyperlipidemia, H2 2014 Number of Products under Development for Hyperlipidemia - Comparative Analysis, H2 2014 Number of Products under Development by Companies, H2 2014 Number of Products under Investigation by Universities/Institutes, H2 2014 Comparative Analysis by Clinical Stage Development, H2 2014 Comparative Analysis by Early Stage Products, H2 2014 Assessment by Monotherapy Products, H2 2014 Number of Products by Top 10 Targets, H2 2014 Number of Products by Stage and Top 10 Targets, H2 2014 Number of Products by Top 10 Mechanism of Actions, H2 2014 www.aarkstore.com

  8. Related Market Research reports: • Corticosteroid-Responsive Dermatoses - Pipeline Review, H1 2014 • Hematological Tumor - Pipeline Review, H1 2014 • Inflammation - Pipeline Review, H1 2014 • Opioid Induced Side Effects - Pipeline Review, H1 2014 • Skin Infections - Pipeline Review, H1 2014 www.aarkstore.com

  9. Related Market Research reports: • Restenosis - Pipeline Review, H1 2014 • Tauopathies - Pipeline Review, H1 2014 • Nasopharyngitis (Common Cold) - Pipeline Review, H1 2014 • Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H1 2014 • Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2014 www.aarkstore.com

  10. Aarkstore - Hyperlipidemia - Pipeline Review, H2 2014 www.aarkstore.com

  11. Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon,  Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614,  Maharashtra, India. 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit : http://www.aarkstore.com OR Mail us at : contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news www.aarkstore.com

More Related